28/07/2026
A New Chapter Begins… 🇬🇧
As our family embarks on a new journey, we are relocating to the United Kingdom to begin the next exciting chapter of Skinska.
This moment is filled with gratitude. I would like to sincerely thank my family, friends, well-wishers, business associates, our dedicated Skinska team, distributors, and, most importantly, the thousands of Consultant Dermatologists and Healthcare Professionals who have trusted and supported Skinska throughout this incredible journey.
Your confidence, encouragement, and belief in our vision have helped transform Skinska from an idea into a trusted dermatology-focused skincare company.
Today, Skinska proudly stands as:
✅ UK SCPN Registered
✅ US FDA Facility Registered
✅ US MoCRA Compliant
With our relocation, I am delighted to share that Skinska UK will now enter its next phase of operations, strengthening our commitment to bringing innovative, clinically driven skincare solutions to healthcare professionals and consumers across the UK, while continuing to expand our global footprint.
This is not a goodbye to India—it is an expansion of our vision. India will always remain our foundation, and from the UK we look forward to building stronger international partnerships, advancing innovation, and creating new opportunities across the UK, USA, and beyond.
Thank you to everyone who has been part of this journey. Your support has made this possible, and I look forward to sharing many more milestones with you.
The best is yet to come.
With gratitude,
Ram Chintalapudi
Founder & CMD
Skinska Pharmaceutica
